Highlights Newsletter 1

This newsletter presents you the following key sessions:

1. Podcast with Prof. Dr. Cappellini about the longer-term analysis of efficacy of luspatercept versus placebo in
    patients with transfusion-dependent beta-thalassemia enrolled in the BELIEVE study

2. Superior PFS with extended KRd versus standard lenalidomide maintenance after stem-cell transplant for
    multiple myeloma

3. Glofitamab effective in patients with relapsed/refractory diffuse large B-cell lymphoma and ≥2 prior therapies

4. Erythropoietin stimulation agents significantly improve outcome in lower-risk myelodysplastic syndrome

5. Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult patients with R/R B-ALL